These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 7313397)
1. [Bromocriptine in fibro-cystic mastopathy]. Marzetti L; Framarino ML; Dei Malatesta ML; Aragona C; De Angelis R Riv Ital Ginecol; 1980; 59(4-5):357-64. PubMed ID: 7313397 [No Abstract] [Full Text] [Related]
2. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline]. Mussa A; Sandrucci S; Dogliotti L Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987 [TBL] [Abstract][Full Text] [Related]
3. [Results of chronic treatment with bromocriptine in patients with fibrocystic mastopathy]. Ablanedo J; Canales ES Arch Invest Med (Mex); 1988; 19(3):225-9. PubMed ID: 3242433 [No Abstract] [Full Text] [Related]
4. [Treatment of benign breast pathology with bromocriptine]. Tolino A; Cardone A; Mastrantonio P; Chiacchio G Riv Ital Ginecol; 1977; 58(5):371-8. PubMed ID: 555037 [No Abstract] [Full Text] [Related]
5. Treatment of benign breast disease with bromocriptine. Mussa A; Dogliotti L J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922 [TBL] [Abstract][Full Text] [Related]
6. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment]. van Bogaert LJ J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218 [TBL] [Abstract][Full Text] [Related]
7. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154). Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of fibrocystic mastopathy with bromocriptine]. López Rosales C; Castellanos Rodríguez J; García Carmona MR Ginecol Obstet Mex; 1985 Aug; 53():233-6. PubMed ID: 3908225 [No Abstract] [Full Text] [Related]
10. Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: update on the European trial. Dogliotti L; Mansel RE Br J Clin Pract Suppl; 1989 Nov; 68():26-32; discussion 49-53. PubMed ID: 2488563 [No Abstract] [Full Text] [Related]
11. [Effect of parlodel and thyroliberin on prolactin secretion in patients with fibrocystic mastopathy]. Sturia NT Probl Endokrinol (Mosk); 1983; 29(2):21-4. PubMed ID: 6406998 [TBL] [Abstract][Full Text] [Related]
12. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine. Murta EF; de Freitas MM; Velludo MA Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021 [TBL] [Abstract][Full Text] [Related]
13. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154). Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613 [TBL] [Abstract][Full Text] [Related]
14. [Mechanisms and effects of bromocriptine in the treatment of breast hyperplasia]. Gao SQ Zhonghua Wai Ke Za Zhi; 1988 Dec; 26(12):733-5, 781-2. PubMed ID: 3248468 [No Abstract] [Full Text] [Related]
16. [Update in the therapy of fibrocystic mastopathy]. Zanoio L; Zacché G; Mainenti M; Silvestre V Minerva Ginecol; 1987 Dec; 39(12):833-8. PubMed ID: 3329703 [No Abstract] [Full Text] [Related]
17. [Medical therapy of cystic mastopathy. A critical review of the literature from 1980 to 1985]. Sismondi P; Giai M; De Fabiani E; Zola P; Barengo R Minerva Ginecol; 1986; 38(7-8):647-57. PubMed ID: 3528925 [No Abstract] [Full Text] [Related]
19. [Therapy of the premenstrual syndrome and especially of cyclic mastodynia with bromocriptine]. Hauser GA Ther Umsch; 1983 Jul; 40(7):604-9. PubMed ID: 6684802 [No Abstract] [Full Text] [Related]
20. [Therapeutic aspects of mammary dysplasia with antiestrogens]. Baracat FF; Pontes MD; Rodrigues de Lima G Rev Paul Med; 1982; 100(3):28-9. PubMed ID: 7184117 [No Abstract] [Full Text] [Related] [Next] [New Search]